{"slug":"vip-tendon","verification":{"valid":true,"entries":2,"head":"2d3d7ad447ee708d64cc968e77fa48f33d38e38a048243ac86eed4f6b984f990"},"energy":{"passes":2,"tokens_in":14899,"tokens_out":2078,"tokens_total":16977,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"2d3d7ad447ee708d64cc968e77fa48f33d38e38a048243ac86eed4f6b984f990"},"provenance":[{"ts":"2026-06-29T22:15:44.722Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Vip for Tendon\nSlug: vip-tendon\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"vip\",\"name\":\"VIP\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"vip\",\"name\":\"VIP\",\"section_title\":\"Why VIP might help you\",\"layer\":\"immune / autonomic\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **VIP** → immune / autonomic\",\"section_headings\":[\"What's breaking down\",\"Why VIP might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chains.\",\"weight_sensitive","response":"{\n  \"slug\": \"vip-tendon\",\n  \"title\": \"VIP for Tendon Repair: What the Data Shows\",\n  \"body\": \"## What's breaking down\\n\\nTendon tissue has limited natural repair capacity. Degeneration often involves chronic low-grade inflammation, disrupted immune balance with excess M1 macrophages, reduced function of tendon stem/progenitor cells (TSPCs), and poor organized collagen deposition. If breakdown outruns repair, tendinopathy persists. VIP is discussed here for its studied effects on immune modulation and tissue repair pathways rather than symptom suppression.\\n\\n## Why VIP might help you\\n\\nIf immune imbalance or poor macrophage polarization contributes to your tendon issue, VIP is examined because it targets repair mechanisms at the tissue level. In one line of research, VIP promoted M2 macrophage polarization, which supports resolution of inflammation and tissue remodeling instead of prolonged pro-inflammatory states. If TSPC function is impaired, the same work showed VIP helped maintain those cells' activity during regeneration. Therefore for you: if that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus. VIP addresses the immune/autonomic layer through modulation of inflammatory homeostasis and support for progenitor cell function in tendon models.\\n\\n## What the evidence actually shows\\n\\nA 2025 preclinical study (Wang et al.) implanted VIP-loaded nanoparticles (VPZG) at patellar tendon injury sites in Sprague-Dawley rats. VIP release promoted tendon regeneration by shifting macrophages toward M2 phenotype, regulating immune balance, and preserving TSPC function. This was an animal model with localized sustained delivery; it demonstrates mechanistic effects in rats but does not prove outcomes in humans. (source s1)\\n\\nEarlier animal work (Delgado et al., 2001) showed VIP reduced incidence and severity of collagen-induced arthritis in mice, with less i","tokens_in":14899,"tokens_out":2078,"cost":0,"prev":"genesis","hash":"61194b46d7f9753790eb7527a1fc2ed703c53df81f1757276ffbda0e8ddce90f"},{"ts":"2026-07-17T02:43:27.900Z","model":"owner","action":"voxel_divide","prompt":"","input":"vip-tendon","response":"20 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"61194b46d7f9753790eb7527a1fc2ed703c53df81f1757276ffbda0e8ddce90f","hash":"2d3d7ad447ee708d64cc968e77fa48f33d38e38a048243ac86eed4f6b984f990"}]}